Research & Stock Picks

Emiten Report

29 May 2023

By

MEDC: Elevated O&G Prices to Give a Leg Up

1Q23 results: Power to the rescue. MEDC posted positive topline growth in 1Q23, with a revenue of USD 558 million (+14% yoy), driven mainly by its power business (USD 111 million, +255% yoy). Meanwhile, O&G sales slipped to USD 393 million (-1.6%) on the back of the decline of crude oil ASP to USD 77.1/bbl (-22.3% yoy) despite higher O&G production of 165 mbopd (+29.9% yoy). MEDC posted an operating profit of USD 178 million (-10.9% yoy); the decline was mainly caused by lower O&G margin (53%, -220 bps) and higher OpEx (USD 54 million, +29.9% yoy). The company’s operating margin fell to 32% (-894 bps). MEDC booked a flattish EBITDA of USD 325 million (+3.8% yoy) and a bottom line of USD 80 million (-11.3% yoy), falling short of ours and cons.

Oil prices to stabilize as Saudi hints production cuts. The recent drop in oil prices (due to weak demand from the US and China) led to a decline in MEDC’s ASP to just USD 77/bbl in 1Q23, compared to USD 100/bbl in 1Q22. However, we cut our FY23F Brent price projection to USD 80/bbl as Saudi and OPEC+ countries hinted that another production cut is in the works. Recently, OPEC+ made another oil production cut of approx.. 1.16 mmbopd, bringing its total production cut to 3.66 mmbopd (3.7% of global oil demand). Our normalized yet elevated oil price thesis is also supported by the decline in US crude inventories, which we believe will continue in the upcoming quarters; however, weak demand from China and the US might be a risk for the price rally, prompting us to cut our projection.

Normalizing oil prices, lower margins = lower forecast. This year, we believe MEDC will reap huge revenue from its gas business, especially with the new GSA contract for the Corridor block and a higher ASP of USD 7.7/mmbtu, which should give MEDC’s O&G business a leg up. However, due to the business’ low margin nature, we have to cut our margin projection to 51%, thus lowering our EBITDA and earnings estimates to USD 1.1 billion and USD 314 million, respectively. Our earnings revision was justified by our recent oil price projection cuts, and with the Ijen Geothermal project coming in full swing, MEDC should experience lower margins from its power business. Furthermore, we are still waiting for the green light for AMNT’s IPO, since it might become a positive catalyst for the slumping MEDC shares (-21.56%.YTD)

BUY, TP IDR 1,600. We maintain our bullish view on MEDC, giving it a BUY and a SOTP-based TP of IDR 1,600, reflecting 4.7x FY23F EV/EBITDA. Main Risks: Declining O&G prices and lifting volume.

Share This:

Download PDF

Download PDF

MEDC_20230529 (EN)
MEDC_20230529 (ID)

Download PDF

MEDC_20230529 (EN)
MEDC_20230529 (ID)

More Related

Daily Stock Technical Recommendations

Mar 19, 2024

Daily Stock Technical Recommendations

Mar 18, 2024

Daily Report

Mar 18, 2024

Daily Stock Technical Recommendations

Mar 15, 2024

Daily Stock Technical Recommendations

Mar 14, 2024

Daily Report

Mar 14, 2024

Daily Stock Technical Recommendations

Mar 13, 2024

Daily Report

Mar 8, 2024

Daily Stock Technical Recommendations

Mar 7, 2024

Daily Report

Mar 6, 2024

Daily Stock Technical Recommendations

Mar 6, 2024

Daily Stock Technical Recommendations

Mar 5, 2024

Daily Report

Mar 4, 2024

Daily Report

Mar 1, 2024

Daily Report

Feb 29, 2024

Daily Report

Feb 28, 2024

Daily Stock Technical Recommendations

Feb 27, 2024

Daily Report

Feb 26, 2024

Daily Stock Technical Recommendations

Feb 26, 2024

Daily Stock Technical Recommendations

Feb 23, 2024

Daily Report

Feb 23, 2024

Daily Stock Technical Recommendations

Feb 22, 2024

Daily Report

Feb 22, 2024

Daily Stock Technical Recommendations

Feb 21, 2024

Daily Report

Feb 21, 2024

Daily Stock Technical Recommendations

Feb 20, 2024

Daily Report

Feb 19, 2024

Daily Stock Technical Recommendations

Feb 19, 2024

Daily Report

Feb 16, 2024

Daily Stock Technical Recommendations

Feb 13, 2024

Daily Report

Feb 13, 2024

Daily Stock Technical Recommendations

Feb 12, 2024

Daily Report

Feb 12, 2024

Daily Stock Technical Recommendations

Feb 7, 2024

Daily Report

Feb 7, 2024

Daily Stock Technical Recommendations

Feb 6, 2024

Daily Report

Feb 5, 2024

Daily Report

Feb 2, 2024

Daily Stock Technical Recommendations

Feb 2, 2024

Daily Stock Technical Recommendations

Feb 1, 2024

Daily Report

Feb 1, 2024

Daily Stock Technical Recommendations

Jan 31, 2024

Daily Report

Jan 31, 2024

Daily Stock Technical Recommendations

Jan 30, 2024

Daily Stock Technical Recommendations

Jan 29, 2024

Daily Report

Jan 29, 2024

Daily Stock Technical Recommendations

Jan 26, 2024

Daily Report

Jan 26, 2024

Daily Stock Technical Recommendations

Jan 25, 2024

Daily Report

Jan 25, 2024

Daily Stock Technical Recommendations

Jan 24, 2024

Daily Report

Jan 24, 2024

Daily Stock Technical Recommendations

Jan 23, 2024

Daily Stock Technical Recommendations

Jan 22, 2024

Daily Report

Jan 22, 2024

Daily Stock Technical Recommendations

Jan 19, 2024

Daily Stock Technical Recommendations

Jan 18, 2024

Daily Stock Technical Recommendations

Jan 17, 2024

Daily Stock Technical Recommendations

Jan 16, 2024

Daily Stock Technical Recommendations

Jan 15, 2024

Daily Stock Technical Recommendations

Dec 29, 2023

Daily Report

Dec 29, 2023

Daily Stock Technical Recommendations

Dec 28, 2023

Daily Report

Dec 28, 2023

Daily Stock Technical Recommendations

Dec 27, 2023

Daily Stock Technical Recommendations

Dec 22, 2023

Daily Report

Dec 22, 2023

Daily Stock Technical Recommendations

Dec 21, 2023

Daily Report

Dec 21, 2023

Daily Stock Technical Recommendations

Dec 20, 2023

Daily Report

Dec 19, 2023

Daily Stock Technical Recommendations

Dec 19, 2023

Daily Report

Dec 18, 2023

Daily Report

Dec 18, 2023

Daily Stock Technical Recommendations

Dec 18, 2023

Daily Stock Technical Recommendations

Dec 15, 2023

Daily Report

Dec 15, 2023

Daily Report

Dec 15, 2023

Emiten Report

Dec 14, 2023

Emiten Report

Dec 14, 2023